Mastocytosis - 30 Studies Found
| Completed |
: Efficacy and Safety of TF002 in Cutaneous Mastocytosis : Cutaneous Mastocytosis : 2007-04-04 : Drug: TF 002 |
| Recruiting |
: Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations :
: 2016-03-15 :
|
| Recruiting |
: A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap :
|
| Terminated |
: Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter :
: 2012-06-07 : Other: QUALITY OF LIFE QUESTIONNAIRE QASICC AND EORTC QLQ-C30 ADMINISTRATION 30 DAYS AFTER CVC IMPLANTAT |
| Recruiting |
: Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis : Systemic Mastocytosis : 2015-05-05 : Procedure: Mastocytosis diagnosis Some samples will be extracted from bone marrow aspirate and periphera |
| Completed |
: Natural History of Urticaria Pigmentosa in Children : Urticaria Pigmentosa : 2007-04-30 |
| Recruiting |
: Mast Cell Connect: A Registry for Patients With Mastocytosis : Mastocytosis : 2015-11-19 |
| Completed |
: The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients : Mastocytosis : 2009-07-20 : Drug: injections subcutaneous injections |
| Completed |
: Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis : Systemic Mastocytosis : 2007-03-19 : Drug: RAD001 (Everolimus) Oral RAD001 10 mg daily for 30 days |
| Completed |
: Imatinib in KIT-negative Systemic Mastocytosis : Systemic Mastocytosis : 2011-02-16 : Drug: Imatinib Mesylate
|